Table 1 Baseline characteristics of all patients
From: Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma
Characteristics | Cases | Percentage (%) |
|---|---|---|
Sex | 310 | Â |
 Male | 174 | 56.1 |
 Female | 136 | 43.9 |
Age at operation (years) | ||
 < 50 | 208 | 67.1 |
 ≥ 50 | 102 | 32.9 |
Performance status | ||
 0 | 237 | 76.5 |
 ≥ 1 | 73 | 23.5 |
Body mass index (kg/m2) | ||
 < 18.5 | 42 | 13.5 |
 ≥ 18.5 to< 25.0 | 208 | 67.1 |
 ≥ 25.0 | 60 | 19.4 |
Pathological types | ||
 Fibrosarcoma | 59 | 19.0 |
 liposarcoma | 37 | 11.9 |
 Undifferentiated pleomorphic sarcoma/MFH | 78 | 25.2 |
 Leiomyosarcoma | 17 | 5.5 |
 Synovial sarcoma | 40 | 12.9 |
 Rhabdomyosarcoma | 19 | 6.1 |
 Alveolar soft part sarcoma | 9 | 2.9 |
 Angiosarcoma | 8 | 2.6 |
 Malignant peripheral nerve sheath tumor | 15 | 4.8 |
 Mesenchymal chondrosarcoma | 8 | 2.6 |
 Others | 20 | 6.5 |
Tumor size (cm) | ||
 < 5 | 143 | 46.1 |
 ≥ 5 | 167 | 53.9 |
Tumor site | ||
 Upper extremity | 35 | 11.3 |
 Lower extremity | 82 | 26.5 |
 Thoracic/trunk/abdominal wall | 91 | 29.4 |
 Intra-abdominal | 48 | 15.5 |
 Head/neck | 48 | 15.5 |
 Others | 6 | 1.9 |
Tumor depth | ||
 Superficial | 127 | 41.0 |
 Deep | 183 | 59.0 |
Tumor grade | ||
 G1 | 82 | 26.5 |
 G2 | 119 | 38.4 |
 G3 | 80 | 25.8 |
 Missing | 29 | 9.4 |
Surgical margin | ||
 R0 | 279 | 95.2 |
 R1 | 9 | 3.1 |
 R2 | 3 | 1.0 |
 Rx | 2 | 0.7 |
AJCC stage | ||
 IA + IB | 83 | 26.8 |
 IIA + IIB | 141 | 45.5 |
 III + IV | 62 | 20.0 |
 Missing | 24 | 7.1 |
NLR | ||
 < 2.51 | 214 | 69.0 |
 ≥ 2.51 | 96 | 31.0 |
PLR | ||
 < 191.1 | 265 | 85.5 |
 ≥ 191.1 | 45 | 14.5 |
FAR | ||
 < 0.0726 | 176 | 56.8 |
 ≥ 0.0726 | 124 | 43.2 |
End-point | ||
 Alive | 212 | 68.4 |
 Dead | 98 | 31.6 |
Recurrence | ||
 YES | 112 | 36.1 |
 NO | 198 | 63.9 |
Metastasis | ||
 YES | 61 | 19.7 |
 NO | 249 | 80.3 |
Adjuvant therapy | ||
 None | 257 | 82.9 |
 Chemotherapy | 14 | 4.5 |
 Radiotherapy | 16 | 5.2 |
 Combined chemoradiotherapy | 2 | 0.6 |
 Unknown | 21 | 6.8 |